Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review. [PDF]
Liszka P +9 more
europepmc +1 more source
Targeting the 5-HT<sub>2A</sub> Receptor for Developing Psychedelic Drugs and Beyond. [PDF]
Ali S, Tian X, Cunningham KA, Zhou J.
europepmc +1 more source
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. [PDF]
Warren AL +12 more
europepmc +1 more source
Acephalgic Migraine Presenting as Episodic Fatigue and Nausea: A Case Report. [PDF]
Oliveira DG.
europepmc +1 more source
Metabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine. [PDF]
Bergh MS +4 more
europepmc +1 more source
Do patients with migraine and obesity receive different treatments? Insights from real-world data. [PDF]
Pardo K +3 more
europepmc +1 more source
AANAT kinetics of CoASH-targeted electrophiles of tryptamine and related analogs. [PDF]
Wandrey N +9 more
europepmc +1 more source
Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice. [PDF]
McGriff SA +5 more
europepmc +1 more source

